Epic Update : Ranbaxy Q3

Consolidated net loss at Rs 454 crore versus profit of Rs 754 crore (YoY)



Consolidated revenue up 3.45 percent at Rs 2,802 crore versus Rs 2,708 crore (YoY)



Consolidated EBITDA down 42 percent at Rs 199 crore versus Rs 344 crore (YoY)



Consolidated operating margin at 7.1 percent versus 12.7 percent (YoY) -Consolidated



forex loss at Rs 360 crore -Ranbaxy says to achieve sales of Rs 13,000-Rs 13,500 crore in FY14



http://www.epicresearch.co/



0731-664-2300

Posted in: Indian Market Tips